Kaiser Permanente | GenomeWeb

Kaiser Permanente

The healthcare provider plans to build a large biobank to conduct precision medicine research based on genomics, lifestyle, and environmental factors. 

The Kaiser Permanente Northwest researchers focused on patient preferences, their ability to handle unexpected results, and the time required for genetic counseling.

The latest analysis of CYP2C19 genotyping to guide antiplatelet therapy tries to address cost questions from the vantage of a payor or large healthcare system.

The three papers published in Genetics will provide the basis for future investigations into the links between genetics, environment, and disease risk.

The partners will conduct a study using electronic medical records to find new best practices for the diagnosis and treatment of ovarian cancer.

A $4.6 million Simons Foundation grant will fund enrollment and initial data collection, but additional resources are necessary for genetic analysis and hypothesis generation.

With $4.6M in funding from the Simons Foundation, Kaiser will collect data from 5,000 families in Northern California.

The firm will use samples and data from Kaiser Permanente hospitals to test its metastatic breast cancer patient-stratification molecular diagnostic assays.

NEW YORK (GenomeWeb) – Pacific Edge announced on Wednesday an agreement with the Southern California Permanente Medical Group for the evaluation of Pacific Edge's gene expression-based test for the detection of bladder cancer.

NEW YORK (GenomeWeb News) – The Melanoma Research Alliance and the Hidary Foundation have awarded $1 million to fund two new genome sequencing-focused research projects aimed at understanding the genetic drivers of acral melanoma, MRA said today.

Pages

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.